Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapid sequence induction: rocuronium-sugammadex versus suxamethonium
2009-013892-23Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Jul 2009
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of rocuronium, Sugammadex and succinylcholine in None (2 arms), sponsored by Rigshospitalet. Primary endpoint: Time to spontaneous respiration. Started Jul 2009; status: completed.
02
Drugs
rocuroniumSugammadexsuccinylcholine
Beyond the preview
Go deeper on 2009-013892-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013892-23.